Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLDX Celldex Therapeudics -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (41)	12/9/2019 12:19:26 PM
From: scaram(o)uche	Respond to of 105

Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to the registration statement include $147,459,779.61 of unsold securities previously registered on the registrant's registration statement on Form S-3 filed on December 2, 2016 which was declared effective by the Securities and Exchange Commission on February 13, 2017 (File No. 333-214882) (as amended, the "Prior Registration Statement"). The Prior Registration Statement registered securities for a proposed maximum aggregate offering price of $250,000,000, of which $147,459,779.61 remain unsold. old registration..... sec.gov Also a mixed shelf. So, despite the 15% hit, there's no substantial change for shareholders.